A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping

NCT02509598 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhabdomyosarcoma
Melanoma

Interventions

DRUG: Tc99m tilmanocept
DRUG: Vital Blue Dye (optional)
PROCEDURE: Lymph Node Mapping

Sponsor

Cardinal Health 414, LLC